Oral Crohn's disease: A favorable clinical response with delayed-release triamcinolone acetonide intralesional injections

American Journal of Gastroenterology

Volumn 103, Issue 11, 2008, Pages 2954-2955

  Mignogna, Michele D ^a   Fortuna, Giulio ^a   Leuci, Stefania ^a   Massimo, Amato ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB; MESALAZINE; TRIAMCINOLONE ACETONIDE;

ABSENCE OF SIDE EFFECTS; ADULT; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; CROHN DISEASE; HUMAN; HUMAN TISSUE; LETTER; MALE; MOUTH INFLAMMATION; ORAL BIOPSY; PRIORITY JOURNAL; TREATMENT RESPONSE;

CROHN DISEASE; GLUCOCORTICOIDS; HUMANS; INJECTIONS, INTRALESIONAL; MOUTH DISEASES; TRIAMCINOLONE;

EID: 55349140733     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2008.02094_16.x     Document Type: Letter

References (5)

1. Harty S, Fleming P, Rowland M, et al. A prospective study of the oral manifestations of Crohn's disease. Clin Gastroenterol Hepatol 2005 3 : 886 91.
2. Danese S, Semeraro S, Papa A, et al. Extraintestinal manifestations in inflammatory bowel disease. World J Gastroenterol 2005 11 : 7227 36.
3. Cardoso H, Nunes AC, Carneiro F, et al. Successful infliximab therapy for oral Crohn's disease. Inflamm Bowel Dis 2006 12 : 337 8.
4. Frankel DH, Mostofi RS, Lorincz AL. Oral Crohn's disease: Report of two cases in brothers with metallic dysgeusia and a review of the literature. J Am Acad Dermatol 1985 12 : 260 8.
5. Brooker JC, Beckett CG, Saunders BP, et al. Long-acting steroid injection after endoscopic dilation of anastomotic Crohn's strictures may improve the outcome: A retrospective case series. Endoscopy 2003 35 : 333 7.